Home › Acute Kidney Injury › New York › New York City
Acute Kidney Injury clinical trials in New York City, NY
6 studies for Acute Kidney Injury are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
Recruiting
- The Mount Sinai Hospital, New York
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RecruitingPhase 2
- Columbia University Irving Medical Center, New York
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
RecruitingPhase 2
- Mount Sinai Medical Center, New York
Kidney Precision Medicine Project
RecruitingObservational study
- Mount Sinai, New York
NIRS Monitoring in the NICU and AKI
RecruitingHealthy volunteers welcome
- NYU Langone Health, New York
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
Recruiting
- Mount Sinai, New York
Acute Kidney Injury trials in other cities
- Cincinnati, OH8 studies
- Birmingham, AL8 studies
- San Francisco, CA7 studies
- Durham, NC7 studies
- Ann Arbor, MI7 studies
- Baltimore, MD7 studies
- Dallas, TX7 studies
- Cleveland, OH6 studies
- Houston, TX5 studies
- Pittsburgh, PA5 studies
- Atlanta, GA5 studies
- Charleston, SC5 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.